Agentic AI platform for medical writing and regulatory documentation
AlphaLife Sciences builds generative AI systems for clinical-stage medical writing and regulatory submissions. The tech stack (Python, Java, JavaScript/TypeScript) and active projects reveal a dual motion: a generative AI medical authoring platform paired with intelligent EDC and data management tools. Hiring velocity is accelerating across sales (4 open roles) and engineering (3), with a notable Finance Director addition — suggesting both GTM expansion and operational scaling as they move from platform development into SaaS delivery at clinical-stage companies.
Notable leadership hires: Finance Director
AlphaLife Sciences develops AuroraPrime, an agentic AI platform that automates medical writing and regulatory documentation for drug development. The company serves clinical development teams and regulatory professionals who manage submissions across therapeutic areas. Founded in 2020 and based in Iselin, New Jersey, the company operates at 51–200 employees. Active projects span generative AI-copiloted medical writing, regulatory authoring models, intelligent data management systems, and scalable sales operations infrastructure. Current pain points center on compliance documentation rigor, audit preparation efficiency, post-sales delivery maturity, and user adoption — typical challenges for early-stage SaaS entering regulated industries.
AuroraPrime, a generative AI platform for automated medical writing, regulatory documentation, and intelligent data management in clinical development workflows.
Python, Java, JavaScript, TypeScript, C/C++, plus Salesforce, HubSpot, Jira, and Confluence for operational infrastructure.
Other companies in the same industry, closest in size